Major depressive disorder (MDD) is a chronic and recurrent ... of such MDD patients remit following adequate antidepressant treatment, while most MDD patients suffer from significant core ...

Psilocybin is under clinical development by Filament Health and currently in Phase I for Major Depressive Disorder.

SPL-026 is under development for the treatment of major depressive disorder (MDD). The drug candidate is a psychedelic N,N-dimethyltryptamine (DMT) based medicine. It is administered through i ...

A mental health professional familiar with cognitive remediation would be the best guide for group treatment. Do you live with major depressive disorder? Learn about the resources and protections ...

About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon ... The diagnosis of major depressive disorder is based on the patient's self-reported ...

HMNC has completed the subject randomisation in its Phase IIb OLIVE trial of BH-200 for major depressive disorder (MDD) treatment.

Sleep problems may be one of the first symptoms of major depressive disorder -- a serious ... the sooner you can get the treatment you need to get you back on your feet. Talk to your doctor ...

Researchers conducted a systematic review and meta-analysis examining the quantitative effect of preventative psychological interventions for major depressive disorder in adults. Psychological ...

Bipolar disorder ... depression but not the full five needed for a major episode. It’s also worth noting that sometimes, but not always, the euphoria of mania can feel enjoyable. Once you get ...

There is limited published data at higher doses and none in the treatment of Major Depressive Disorder (MDD). Methods This open-label, pilot study was designed to investigate the efficacy ...